Influenza outbreak

RECENT NEWS
FiercePharma  May 16  Comment 
The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drugmaker has a domestic facility with egg-based vaccine production capabilities.
The Hindu Business Line  May 1  Comment 
H1N1 influenza has claimed 23 lives in Kerala so far this year with the State recording higher incidence of the flu compared to the previous year. According to health department officials, about 30...
Insurance Journal  Apr 25  Comment 
Officials say they have ended restrictions on poultry producers that were enacted after the first confirmation of avian influenza in commercial birds in Georgia. News outlets report state veterinarian Robert M. Cobb Jr. said in a news release that...
The Hindu Business Line  Apr 18  Comment 
WTO’s Dispute Settlement Body will consider New Delhi’s request today
Agrimoney.com  Apr 7  Comment 
Higher slaughter rates, and rivalry from poultry supplies boosted by the fallout from bird flu, will keep a lid on cattle values, the bank says
DailyFinance  Apr 4  Comment 
Filed under: News, Innovation - Health, Science & Tech A Minnesota woman's heartbreaking note about losing her daughter to influenza has begun making rounds on the internet. Read more...   Permalink | Email...
Insurance Journal  Mar 31  Comment 
Minnesota is better prepared for a potential bird flu return after a devastating 2015 epidemic, according to poultry producers and experts. Poultry farmers are waiting as the early spring opens water on lakes and rivers, leading to the migration...
Insurance Journal  Mar 30  Comment 
About 18,000 chickens were destroyed at a northwest Georgia poultry farm after tests confirmed avian influenza in the flock, the first time the disease has been detected in commercial birds in the state, authorities said Monday. The infected...
MarketWatch  Mar 28  Comment 
Producers in the state with the biggest poultry industry are on high alert after about 18,000 chickens were destroyed.
Agrimoney.com  Mar 27  Comment 
Egg production in the US has recovered, but not demand, even as new cases of bird flu are reported




 
TOP CONTRIBUTORS

Influenza, or the flu, is a common infectious disease, which can be deadly to individuals with compromised immune systems (the very young, the very old, and those with conditions such as AIDS or Cancer). However, occasionally particularly virulent strains of influenza break out that can be threatening on a much larger scale -- such as the flu epidemic of 1918 and, more recently, concerns that H5N1 "Bird Flu" or H1N1 "Swine Flu" could mutate into a highly-infectious and deadly virus. A number of pharmaceutical companies make treatments for the flu and benefit from the fear of a flu outbreak.


  • Roche Pharmaceuticals makes Tamiflu, an antiviral pill to treat the flu. In 2005, amid concerns that bird flu might pose a large threat during the winter flu season, many national governments began stocking up on Tamiflu. Chugai pharmaceuticals sells Tamiflu in Japan.
  • Novartis AG (NVS), through its acquisition of Chiron in 2006, supplies much of the traditional flu vaccine supply to the United States.
  • AstraZeneca (AZN), through recently acquired MedImmune, manufactures 'FluMist', a novel flu vaccine that is delivered via an intranasal spray rather than via an injection.

Companies with treatments for H1N1, or "Swine Flu"

In April 2009, a novel flu virus, known as "Swine Flu" because it was believed to have originated in pigs, started infecting humans. By April 28th, there were 1,300 confirmed cases of the flu, known by its scientific designation H1N1, in Mexico, and a handful in the U.S. and other parts of the world.

According to preliminary test done by the US Center for Disease Control, Roche Pharmaceuticals (RHHBY)'s Tamiflu and GlaxoSmithKline (GSK)'s Relenza are active against H1N1, although many older drugs are not. [1]

References

  1. Investors buy up shares of flu drug makers, New York Times, April 27th 2009.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki